Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Researchers are studying it mainly for weight loss and metabolic health.[drugwatch]What is it used for?It is being studied for obesity, type 2 diabetes, and related metabolic conditions
Vit-D can modulate both innate and adaptive immune responses, and vit-D deficiency is linked to increased autoimmunity as well as increased susceptibility to microbial infections
At PrimeHealth Primary Care, our team is committed to helping patients regulate appetite, reduce cravings, and build lasting lifestyle changes for healthier living
The dual-agonist approach appears to produce greater glycemic control and weight reduction compared to selective GLP-1 receptor agonists in clinical trials
We think Amgen's going to be an important participant in this global health crisis. Amgen joins an increasingly competitive field: Eli Lilly recently saw its chronic weight product, injectable ZepBound (tirzepatide), approved by the FDA, while Novo Nordisk already has two weight-loss peptides on the market, Saxenda (liraglutide) and Wegovy (semaglutide)
Hypoglycaemia (low blood glucose) can occur, particularly when tirzepatide is used in combination with insulin or sulphonylureas
